PATH
Menu

Filter browse results

Total results with these characteristics: 89

Subject: Reproductive health > Cervical cancer prevention

Page 3 of 5
Shaping a Strategy to Introduce HPV Vaccines in India

This document presents formative research results from PATH's HPV Vaccines: Evidence for Impact project in India. PATH is working with ministries of health and other country partners to develop strategies for introducing vaccines against human papillomavirus (HPV), the primary cause of cervical cancer.

Publication date: March 2009

Region: Asia

Shaping a Strategy to Introduce HPV Vaccines in Peru

This document presents new research results from PATH's HPV Vaccines: Evidence for Impact project in Peru. PATH is working with ministries of health and other country partners to develop strategies for introducing vaccines against human papillomavirus (HPV), the primary cause of cervical cancer.

Publication date: March 2009

Region: Latin America

Shaping a Strategy to Introduce HPV Vaccines in Uganda

This document presents new research results from PATH's HPV Vaccines: Evidence for Impact project in Uganda. PATH is working with ministries of health and other country partners to develop strategies for introducing vaccines against human papillomavirus (HPV), the primary cause of cervical cancer.

Publication date: March 2009

Region: Africa

Shaping a Strategy to Introduce HPV Vaccines in Vietnam

This document presents formative research results from PATH's HPV Vaccines: Evidence for Impact project in Vietnam. PATH is working with ministries of health and other country partners to develop strategies for introducing vaccines against human papillomavirus (HPV), the primary cause of cervical cancer.

Publication date: March 2009

Region: Asia

Directions in Global Health (Volume 5, Issue 3)

This issue of Directions in Global Health describes PATH's work to control and prevent diarrheal disease, reach out to young scouts in Kenya and Uganda with HIV/AIDS information, assess the impact of malaria control efforts in Zambia, conduct DHS surveys, and shape HPV vaccine introduction in Peru.

Author: PATH

Publication date: December 2008

Region: Global

Part of series: Directions in Global Health

PATH Today (Spring 2008)

This edition of PATH Today highlights the first tour of PATH Journeys, our newly established donor travel program. Also featured are PATH's Sure Start program, a thank-you to the sponsors of our 2008 Breakfast for Global Health, and information on two endeavors to protect women from disease and violence: the Global Call to Stop Cervical Cancer and the International Violence Against Women Act.

Publication date: May 2008

Region: Global

Part of series: PATH Today

HPV Vaccine Adoption in Developing Countries: Cost and Financing Issues

Financing the human papillomavirus (HPV) vaccine and mobilizing resources to support new delivery mechanisms will constitute some of the most significant challenges to achieving widespread HPV vaccination in the developing world. Country decision-makers will need to weigh the value of HPV vaccines against other national health priorities, against other vaccines entering the market, and, for some countries, against expanding coverage of existing vaccines. With these cost and financing obstacles resolved, developing countries would be able to build robust programs to immunize adolescents and thus dramatically reduce the incidence of cervical cancer.

Publication date: December 2007

Region: Global

Making Cervical Cancer Vaccines Widely Available in Developing Countries: Cost and Financing Issues

Financing the human papillomavirus (HPV) vaccine and mobilizing resources to support new delivery mechanisms will constitute some of the most significant challenges to achieving widespread HPV vaccination in the developing world. This brief summarizes the main findings of the longer research publication, HPV Vaccine Adoption in Developing Countries: Cost and Financing Issues.

Publication date: December 2007

Region: Global

PATH Today (Winter 2007)

This edition of PATH Today features a main article about the neveripine pouch, "Protecting newborns against HIV," and includes updates on the Meningitis Vaccine Project's plans to introduce a vaccine in Burkina Faso in 2008, PATH's nomination as a Laureate for the Tech Museum Awards, and the organization's recognition as a top social entreprenuer in Fast Company magazine. The issue also includes details about the Gates Partnership Challenge and other opportunities for donors to engage and learn about PATH.

Publication date: December 2007

Region: Global

Part of series: PATH Today

Preventing Cervical Cancer: Unprecedented Opportunities for Improving Women's Health (Outlook, vol. 23, no. 1)

For the latest Outlook issue on cervical cancer prevention, please see Progress in Preventing Cervical Cancer: Updated Evidence on Vaccination and Screening (Outlook, vol. 27, no. 2).

Author: Castilaw D, Wittet S

Publication date: July 2007

Region: Global

Part of series: Outlook

Cervical Cancer, Human Papillomavirus (HPV) and HPV Vaccines: Key Points for Policy-Makers and Health Professionals

This booklet summarizes and updates the World Health Organization (WHO) document Human Papillomavirus and HPV Vaccine: Technical Information for Policy-Makers and Health Professionals and the WHO/UNFPA guidance note Preparing for the Introduction of HPV Vaccines—Policy and Programme Guidance for Countries. They are available in the STIs/RTIs section of the WHO website.

Publication date: 2007

Region: Global

Detection of High-Risk HPV-E6 Oncoprotein in Low and High-Grade Cervical Intraepithelial Neoplasia (CIN): Emerging Evidence for Predictive Validity

This poster demonstrates the predictive validity of an assay developed by Arbor Vita and PATH. For this study, cervical swab specimens collected from women screened, diagnosed, and managed in rural settings in China were tested for the presence of HPV-16 DNA then examined for HPV16-E6 expression. Results confirmed E6 is a potential diagnostic marker. Presented at: 23rd Papillomavirus Conference and Clinical Workshop, September 1, 2006; Prague, Czech Republic.

Author: Schweizer J, Somoza C, Mahoney C, et al

Publication date: October 2006

Region: Global

Developing a Lateral Flow Strip Test for E6 Oncoprotein to Identify Cervical Intraepithelial Neoplasia (CIN) at Increased Risk of Progression to Cervical Cancer

This poster outlines the evaluation of two immunochromatographic strip test platforms for the best limit of detection: one uses an antibody colloidal gold conjugate which is visually interpreted yielding qualitative results, and the other uses an antibody paramagnetic particle conjugate which is read by an instrument yielding quantitative results. The resulting limits of detection of these two methods are compared to the target limit of detection for an E6 assay of ~50 pg. Presented at: 23rd Papillomavirus Conference and Clinical Workshop, September 1, 2006; Prague, Czech Republic.

Author: Peck R, Weigl BH, Schweizer J, et al

Publication date: October 2006

Region: Global

Development of a Diagnostic Assay Based on the Binding of High-Risk HPV-E6 Oncoproteins to PDZ

A prototype of a novel diagnostic assay for cervical pre-cancer and cancer has been developed in both a sandwich ELISA-based and a lateral flow–based format (“strip test”). The test specifically detects presence of high-risk HPV-E6 and therefore promises to be of higher predictive value for cervical pre-cancer and cancer than other assays detecting merely presence of HPV. Presented at: 22rd International Papillomavirus Conference and Clinical Workshop, September 1, 2006; Vancouver, Canada.

Author: Schweizer J, Somoza C, Peck R, et al

Publication date: October 2006

Region: Global

PATH Today (Fall 2006)

Publication date: October 2006

Region: Global

Part of series: PATH Today

Cervical Cancer Prevention in Western Province

This is one of a series of fact sheets that describe PATH's current and past work in Kenya. The fact sheets focus on specific projects as well as unique approaches that cut across projects. This fact sheet describes the work of the Western Kenya Cervical Cancer Prevention Project.

Publication date: July 2006

Region: Africa

A Test for Detection of HPV-16 E6

Demonstration of the use of a magnetic immunochromatographic strip (ICS) assay with a reader to detect recombinant HPV-16 E6. The magnetic ICS assay was able to detect as little as 2.6ng of protein. Presented at: 38th Annual Oak Ridge Conference, April 20, 2006; San Jose, CA.

Author: Peck R, Schweizer J, Weigl B, et al

Publication date: May 2006

Region: Global

Current and Future HPV Vaccines: Promise and Challenges

This 72-page document offers an in-depth look at vaccines against human papillomavirus (HPV), both currently available vaccines and those in development, including therapeutic vaccines. The document includes an examination of programmatic issues relevant to developing countries.

Author: Kols A

Publication date: 2006

Region: Global

A New HPV-DNA Test for Developing Countries

Demonstration of a new 48-well HPV DNA batch test showing analytical sensitivity to 5000 copies of HPV DNA and other test characteristics that may be suitable for use in low-resource settings. Presented at: 22nd International Papillomavirus Conference, April 30, 2005; Vancouver, BC.

Author: Eder P, Nazarenko I, Peck R, Weigl B, Sellors J, Lorincz A

Publication date: May 2005

Region: Global

Introducing HPV Vaccines in Developing Countries: Overcoming the Challenges

This fact sheet focuses on the challenges of introducing HPV vaccines into developing countries.

Author: Herdman C; Demspey M

Publication date: 2005

Region: Global

Page 3 of 5